Singapore's A-Bio Pharma and Artisan Pharma, Inc. Announce Strategic Manufacturing Alliance on ART-123

19-Sep-2007 - Artisan Pharma, Inc. and A-Bio Pharma Pte Ltd. announced that they have finalized a strategic and mutually exclusive manufacturing relationship on the process development, scale-up and manufacture of ART-123, a recombinant protein for the treatment of DIC (disseminated intravascular coagulation) ...

Bio*One Capital's A-Bio Pharma Secures A Second Deal With GlaxoSmithKline

$9 million Expansion of Facility Underway

18-Aug-2005 - Bio*One Capital Pte Ltd, a leading biomedical sciences investment management company, announced that its portfolio company A-Bio Pharma Pte Ltd (A-Bio), has clinched its second process development and clinical supply service agreement with GlaxoSmithKline Biologicals (GSK Bio) via the signing of ...

A-Bio Secures Major Deal with Novo Nordisk

01-Jun-2005 - A-Bio Pharma Pte Ltd (A-Bio) announced that it has entered into a multi-year Master Service Agreement with Novo Nordisk A/S. Under the agreement, Novo Nordisk will engage A-Bio for process development and GMP clinical supply of biologics in its pipeline of biopharmaceutical projects. "We are ...

A-Bio Announces Process Development and Clinical Supply Service Agreement with GlaxoSmithKline Biologicals

Agreement with a World Vaccine Leader Marks Major Milestone for Singapore Biologics Contract Manufacturer

04-Nov-2004 - Singapore. A-Bio Pharma Pte Ltd (A-Bio) announced that the company has entered into a process development and clinical supply service agreement with GlaxoSmithKline's vaccine division, GlaxoSmithKline Biologicals (GSK Bio) via the signing of an agreement with Glaxo Wellcome Manufacturing PTE Ltd. ...